TY - JOUR
TI - Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10%
AU - Kontochristopoulos, G.
AU - Markantoni, V.
AU - Agiasofitou, E.
AU - Platsidaki, E.
AU - Kouris, A.
AU - Campanati, A.
AU - Offidani, A.M.
AU - Rigopoulos, D.
AU - Gregoriou, S.
JO - Journal of the European Academy of Dermatology and Venereology
PY - 2021
VL - 35
TODO - 8
SP - e524-e526
PB - John Wiley and Sons Inc
SN - 0926-9959, 1468-3083
TODO - 10.1111/jdv.17297
TODO - glycopyrronium;  lisote cream;  oxybutynin;  sofipironium bromide;  umeclimidium;  unclassified drug;  mandelic acid derivative;  oxybutynin, comparative effectiveness;  cream;  Dermatology Life Quality Index;  disease severity assessment;  drug approval;  drug dosage form comparison;  drug efficacy;  drug safety;  human;  hyperhidrosis;  Japan;  Letter;  protein bound iodine;  quality of life;  treatment withdrawal;  United States;  urine incontinence;  axilla;  hyperhidrosis;  treatment outcome, Axilla;  Humans;  Hyperhidrosis;  Mandelic Acids;  Quality of Life;  Treatment Outcome
TODO - null
ER -